| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FA complementation group M | 0.543 | 0.731 | 2.4E-15 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
TYRO3 protein tyrosine kinase | 0.559 | 0.769 | 8.3E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
apolipoprotein D | 0.584 | 0.577 | 5.4E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2003 | 2003 | ||||||||
|
GLI family zinc finger 3 | 0.436 | 0.846 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
paired like homeobox 2B | 0.565 | 0.731 | 0.94 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1990 | 1990 | ||||||||
|
NF-kappaB interacting lncRNA | 0.711 | 0.423 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
neural precursor cell expressed, developmentally down-regulated 9 | 0.548 | 0.769 | 0.13 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2002 | 2002 | ||||||||
|
myocardin related transcription factor A | 0.572 | 0.615 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
SCY1 like pseudokinase 1 | 0.582 | 0.769 | 2.5E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2002 | 2002 | ||||||||
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
phosphoglycolate phosphatase | 0.606 | 0.808 | 0.16 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
microRNA 504 | 0.670 | 0.462 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | |||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.010 | None | < 0.001 | 1 | 2 | 2014 | 2014 | ||||||||
|
GLI family zinc finger 1 | 0.431 | 0.846 | 7.7E-14 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
cadherin 13 | 0.501 | 0.846 | 7.1E-04 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2002 | 2004 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2002 | 2019 | ||||||||
|
galectin 3 | 0.392 | 0.846 | 2.3E-05 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2009 | 2019 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2007 | 2010 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2003 | 2019 | ||||||||
|
synaptophysin | 0.481 | 0.808 | 0.92 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2018 | ||||||||
|
H1.0 linker histone | 0.663 | 0.692 | 0.64 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1996 | 2004 | ||||||||
|
Alzheimer disease 12 | 0.711 | 0.538 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1982 | 1982 | |||||||||
|
COMMD3-BMI1 readthrough | 0.488 | 0.769 | 1.5E-03 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2007 | 2015 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2015 | 2017 |